Fenugreek considerations Fenugreek can interact with blood thinners and may affect blood clotting
Zepbound has FDA approval for two main uses: Chronic weight management in adults with obesity or adults who are overweight with one or more obesity-related health conditions, such as high blood pressure, diabetes, or high cholesterol
Offering an anesthesiologists perspective on the study, Paul Potnuru, MD, an assistant professor in the Department of Anesthesiology, Critical Care, and Pain Medicine at UTHealth Houston and not involved in the study, called the findings somewhat reassuring but said the risk for aspiration was still a consideration
Complete the form below to access these webinars: January 21, 2025 On-Demand Access: Mastering GLP-1 Compounding Series Q&A Roundup Frier Levitts healthcare and pharmacy law attorneys present a follow-up webinar Mastering GLP-1 Compounding Series Q&A Roundup, where they tackle key issues based on the September 13, 2024 Mastering GLP-1 Compounding, a Comprehensive 3-Part Webinar Series Tailored for Pharmacy Professionals (On-Demand Access) Stay ahead in 2025: Discover whats on the horizon for GLP-1 compounding as we navigate evolving FDA guidelines and state Boards of Pharmacy regulations
Constipation vs Diarrhea: Why Zepbound Can Cause Both Individual Digestive Differences Zepbound (tirzepatide) slows gastric emptying and alters hormone signals in the gut
And a small number of people have suffered severe abdominal pain after taking the medications, with nausea and diarrhea among the more common side effects, research shows